Purine nucleoside phosphorylase (PNP; EC 2.4.2.1) deficiency is thought to cause T-lymphocyte depletion by accumulation of dG and dGTP, resulting in feedback inhibition of ribonucleotide reductase (RR; EC 1.17.4.1) and hence DNA synthesis. To test for additional toxic mechanisms of dG, we selected a double mutant of the mouse T-lymphoma S-49 cell line, dGuo-L, which is deficient in PNP and partially resistant to dGTP feedback inhibition of RR. The effects of dG on dGuo-L cells (concn. causing 50 % inhibition, IC50 = 150 1uM) were compared with those on the wild-type cells (IC50 = 30 4M) and the NSU-1 mutant with PNP deficiency only (IC50 = 15 /tM). Fluorescence flow cytometry showed that equitoxic dG concentrations arrested wild-type and NSU-1 cells at the G1-S interface while allowing continued DNA synthesis in the S-phase, whereas the double mutant dGuo-L cells progressed through the cell cycle normally. dGuo-L cells accumulated high levels of dGTP in G,-phase, but not in S-phase cells, because of the utilization of dGTP for DNA synthesis and limited capacity to synthesize dGTP from dG. These results support the hypothesis that dG/dGTP toxicity occurs in the G,-phase or at the G1-S interface. Failure of dG to arrest the double mutant dGuo-L cells at the G1-S interface allows these cells to escape into S-phase, with an accompanying drop in dGTP levels. Thus the partial resistance of dGuo-L cells to dG toxicity may result from their shorter residence time in G1, allowing them to sustain higher dGTP levels. Hence RR inhibition by dGuo may not be the primary toxic mechanism in S-49 cells; rather, it may serve as an accessory event in dG toxicity by keeping the cells in the sensitive phase of the cell cycle. Among the possible targets of dG toxicity is RNA synthesis, which was inhibited at an early stage in dGuo-L cells.
INTRODUCTION
An inborn deficiency of purine nucleoside phosphorylase (PNP; EC 2.4.2.1) results in severe immunodeficiency that is characterized by marked T-lymphocyte depletion and normal Blymphocyte functions [1, 2] , in contrast with a combined severe immunodeficiency caused by adenosine deaminase deficiency, in which both B-and T-lymphocyte functions are affected [3, 4] . Whereas multiple mechanisms have been reported for ADA deficiency ( [5] and refs. therein), the predominant cause of Tlymphocyte toxicity in PNP deficiency is thought to be the accumulation of dG and its metabolite, dGTP [6, 7] , which causes feedback inhibition of ribonucleotide reductase (RR; EC 1.17.1) activity towards CDP [5, 8] and enhances ADP reduction [9] . The selectivity of dG cytotoxicity against Tlymphocytes may rest in the ability of these cells to trap dGTP inside the cell by high kinase and low nucleotidase activities [10, 11] . dGuo and its analogues are therefore considered to be potential chemotherapeutic agents for leukaemias [12] . However, the hypothesis of RR inhibition by dGTP failed to explain the early toxicity caused by rather high dG levels before initiation of DNA synthesis in concanavalin-A-stimulated murine spleen Tlymphocytes [13] , the selective sparing of T helper cell activity required for normal B-lymphocyte function [14, 15] , or the inability of deoxycytidine to reverse dG effects on phytohaemagglutinin-stimulated human peripheral blood lymphocytes [11, 16] . Finally, several studies on dG toxicity were performed in cells with normal PNP activity, allowing for dG conversion to guanine and subsequent guanine toxicity (e.g. [8, 17] ). Therefore the purpose of this study is to address additional mechanisms of dG that may have implications in its immunological effects and cytotoxicity.
To investigate cytotoxic effects of dG that are independent of feedback inhibition of RR, we selected a mouse T-lymphoma cell line, dGuo-L [18] . This double-mutant of the parent S-49 mouse cells is devoid of PNP and heterozygous for an RR allele resistant to dGTP feedback regulation [18] . The results were compared with those obtained in the parent S-49 wild-type cells and in PNP-deficient mutant cells from which the mechanism involving RR inhibition was derived [5] . Our results suggest that RR inhibition may not be the primary mechanism of dG toxicity against S-49 cells, but rather serves to maintain cells in the sensitive phase, G1 or G1-S interphase, of the cell cycle.
MATERIALS AND METHODS Materials
5-Bromodeoxyuridine (BrdU), chromomycin A , dG, N6,2'-O-dibutyl cyclic AMP (Bt2cAMP), ethidium bromide, Freon (1,1,2-trichloro-1,2,2-trifluoroethane), iodoacetic acid, propidium iodide, proteinase K, tri-n-octylamine, Tris buffer and Triton X-100 were purchased from Sigma Chemical Co., St Lawrence Livermore Laboratory, Livermore, CA, U.S.A. Vanadyl-ribonucleotide complex was purchased from BRL Life Technology, Gaithersburg, MD, U.S.A. SDS, electrophoresisgrade agarose and urea were purchased from Bio-Rad Laboratories, Richmond, CA, U.S.A. All other reagents were of analytical grade.
Cell culture S-49 wild-type, NSU-1 (PNP-deficient) mutant and dGuo-L mutant cells were cultured in Dulbecco's modified Eagle's medium with 10 % heat-inactivated horse serum at 37°C in 10 % C02. The growth characteristics ofthese cells have been described elsewhere [18] . For growth experiments, dG was added to exponentially growing cells (5 x 105/ml) for 24 h. Cell counts were then determined with a Coulter counter model Zf. For G1-phase enrichment, S-49 cells were incubated with 500 ,uMBt2cAMP for 24 h and washed with phosphate-buffered saline (PBS; 10 mM-sodium phosphate, 120 mM-NaCl and 2.7 mM-KCl, pH 7.4) immediately before experiments. S-phase-enriched cell populations were obtained 24 (22,m) and analysed directly using a dual-laser FACSII flow cytometer. To compare the rates at which BrdU-labelled control and dG-treated cells progress through the cell cycle, the percentage of BrdU-labelled cells in the G1-, S-, and G2/M-phases at different sampling times was calculated as described [22] . Further, DNA synthesis time (T.)
was also calculated for both control and dG-treated cells at different times of sampling, as previously described by Begg et al. [23] .
RNA synthesis in cell homogenates Exponentially growing dGuo-L cells were harvested by centrifugation, washed twice with cold PBS and resuspended in a buffer containing 150 mM-sucrose, 80 mM-KCI, 35 mM-Hepes, 5 mM-potassium phosphate and 5 mM-MgCl2, pH 7.4, at 2 x 108 cells/ml. Portions of the cell suspension (0.8-1 ml) were homogenized with a Brunsmith Ultrasonic cell disrupter (micro tip) with 60 pulses (20 % active cycle) at power output level 2. Cell homogenate (25 g1l) was added to 75 ,u1 of reaction mixture in a buffer containing 50 mM-Hepes, 7.5 mM-potassium phosphate and 10 mM-MgCl2, pH 7.4, giving final concentrations of 1 mM-dithiothreitol, 0.5 mM-ATP, -CTP and -UTP, and 0.1 mM-[3H]GTP (specific radioactivity 222 d.p.m./pmol). Alternatively, 1 mM-dithiothreitol, 0.5 mM-ATP, -CTP and -GTP and 0.1 mM-[3H]UTP were used. The reaction mixture was supplemented with 0-2.5 mM-dGTP or -dATP and incubated at 37°C for 1-60 min. RNA-or polynucleotide-bound radioactivity was determined as described [24] .
Isolation and electrophoresis of cytoplasmic RNA [3H]Gua-labelled cells were washed with ice-cold PBS and resuspended in iced lysis buffer C (10 mM-Tris, pH 7.0, 10 mMNaCl, 0.2 % Triton X-100, 1 % ethanol and 100 mM-vanadylribonucleotide complex). The mixture was vortex-mixed and kept on ice for 10 min. After centrifugation, the supernatant (containing cytoplasmic RNA) was removed, and 0.2 vol. of lysis buffer D (100 mM-Tris/HCI, 50 mM-EDTA and 10% SDS, pH 7.1) was added. The solution was incubated with proteinase K (final concentration 200 ,g/ml) at 37°C for 30 min followed by three extractions with phenol/chloroform/isoamyl alcohol (25:24:1, by vol.). Extracted cytoplasmic RNA was stored in 100 % ethanol containing 0.2 M-NaCl at -20°C overnight before analysis. Electrophoresis of [3H]RNA was performed using vertical 1.5% agarose gels containing 6 M-urea and 0.015 Miodoacetate in a TPE running buffer (0.04 M-Tris, 0.036 MNaH2PO4, and 0.001 M-EDTA, pH 7.4) at constant voltage (40 V) for 12 h. RNA bands were then revealed by staining with ethidium bromide. Incorporation of 3H into different size classes of RNA was determined by fractionation of the gels and liquid scintillation counting of the gel slices.
RESULTS

Inhibition of S49 cell growth by dG
Over a 24-h incubation, dG inhibited growth of wild-type S-49, PNP-negative (NSU-1) and the double-mutant (dGuo-L) [18] , who attributed the lower sensitivity of dGuo-L cells to a partial loss of feedback inhibition of RR by dGTP. [25] ). Surprisingly, however, [3H]dG labelled the dGTP pool up to 3-fold more efficiently in G,-phase-than in S-phase-enriched cells (Fig. 1) . centrations of dG up to 350 4aM, whereas RNA synthesis declined sharply between 50 and 100 1sM-dGuo (Fig. 2) . The specific 14C radioactivity of the GTP pool (from [14C]Gua), measured after 4 h of incubation, slightly decreased with increasing dG concentrations in the medium. However, the decrease in specific 14C radioactivity was at most 25 %, and therefore did not account for the fall in RNA tracer incorporation. Further, the lower 14C specific radioactivity of GTP was compensated for by considering the small contribution of 3H from dG that also entered the GTP pool (by the 5 % residual PNP activity in dGuo-L cells). Hence dG caused a sizeable fall in RNA synthesis in dGuo-L cells, but it had no effect on DNA synthesis. Gel electrophoresis of cytoplasmic RNA from dGuo-L cells Cytoplasmic RNA species were extracted with phenol/chloroform and fractionated on an agarose/urea gel. Densitometric analysis of the photographic negative showed that the amounts of 28 S rRNA, 18 S rRNA or tRNA as percentages of total cytoplasmic RNA were unchanged by dG over a 4-h incubation period (results not shown). However, 350,M-dG differentially depressed [3H]Gua incorporation into 28 S rRNA, 18 S rRNA and tRNA by 44 %, 46 % and 20 % respectively (Table 2) .
Protein synthesis in dGuo-L cells
In dGuo-L cells, the incorporation of [3HjLeu into protein was also inhibited by dG in a dose-dependent fashion. The inhibition was more profound after longer dG exposure. For example, 100 1tM-dG caused 20, 30 and 40 % falls in tracer incorporation at 4, 8 and 16 h of incubation respectively. Comparing the time course of inhibition by dG of [3H]U and [3H]Leu incorporation into RNA and protein respectively suggested that the RNA effect was already pronounced at earlier time points (4 h), whereas the inhibition of [3H]Leu incorporation was rather small at 4 h. and dGuo-L cells respectively), flow cytometric analysis of total DNA content with chromomycin A3 demonstrated a G1-S interface blockade in the wild-type and NSU-1 cells, but not in dGuo-L cells (Fig. 3) . In contrast, dGuo-L cells accumulated slightly in the G2/M phase. Qualitatively similar changes were also observed at lower dG concentrations for all three cell lines. In order to investigate the mechanism of these changes, we performed dual-staining flow cytometry with BrdU and propidium iodide (Fig. 4) . With dGuo-L cells, the progression of high-intensity green fluorescence (anti-BrdU antibody) that moved from S phase towards G2/M phase (Fig. 4a, parts a, f-g) and finally back to G,-phase of the cell cycle (Fig. 4a , h-i) was largely unchanged by dG as compared with the control (Fig.4, a-e) .
On the other hand, upon dG treatment of PNP-deficient mutant NSU-1 cells (Fig. 4b) and of S-49 wild-type cells (results not shown), BrdU-labelled S-phase cells continued cycling through G2/M-phase, appeared back in G1-phase, and were blocked at the G1-S interface for at least 12 h (Fig. 4b, a,f-i) . The slight accumulation of dGuo-L cells in G2/M (Fig. 3) first suggested a possible M-phase blockade, since the assembly of tubulin into the mitotic apparatus requires GTP binding to tubulin subunits which might be interfered with by dGTP [28] . Quantitative analysis of the percentage of BrdU-labelled cells in each phase over time, however, gave superimposable plots of the rates of cell cycle progression. The mean T, (DNA synthesis time [23] ) for dG-treated and control dGuo-L cells was 8.09 and 8.10 h respectively. Therefore the small accumulation of the G2/M peak did not represent a G2/M blockade. Rather, the larger than normal G2/M peak could result from faster cell death occurring in G1-or S-phase cells.
DISCUSSION
We have compared the effects of dG on a double-mutant mouse T-lymphoma cell line, dGuo-L, which is PNP-deficient and has an altered RR (partially resistant to dGTP regulation), compared with wild-type S-49-cells from which the RR hypothesis was derived [5] , and with another mutant cell line, NSU-1, with PNP deficiency only.
New insights into the cytotoxic mechanism of dG by RR inhibition were gained with the combined use of tracer incorporation into DNA and analysis of cell cycle progression of S-49 wild-type and PNP-deficient (NSU-1) cells. Although dG decreased tracer incorporation into DNA, the effect was rather modest over at least the first 4 h even in the presence of toxic dG concentrations. Flow-cytometric DNA analysis revealed that the cell cycle was rapidly blocked at the G1-S interface and the Sphase cells were progressively depleted (Fig. 3) . The decreasing fraction of S-phase cells paralleled the observed progressive decrease of tracer incorporation into DNA over time. These results when combined indicate that DNA synthesis in the remaining S-phase cells was affected by dG only marginally or not at all. This conclusion was confirmed with the anti-BrdU antibody flow-cytometric analysis of cell-cycle progression: Sphase cells continued to progress through S and G2/M into G1-phase even in the presence of high concentrations of dG (Fig. 4) . In contrast, no G1-S interface block was observed in the double mutant, dGuo-L, and the cells cycled normally through the cell cycle, which indicated that RR inhibition was not involved in dG toxicity against the double mutant.
In view of the strong previous evidence that dG toxicity in the S-49 wild type and NSU-1 cells is associated with feedback inhibition of RR by dGTP [5] , the paradoxical failure of dG to inhibit DNA synthesis in S-phase cells needed to be resolved. The dramatic differences in dGTP accumulation in G1-and S-phase cells can resolve this paradox. G.-phase NSU-1 and dGuo-L cells slowly and extensively accumulate dGTP (for kinetics see [25] ), whereas S-phase cells show a much faster turnover rate because of ongoing DNA synthesis, and hence accumulate much less dGTP from dG. Further, we have previously shown that the direct synthesis of dGTP from dG has limited capacity relative to dGTP utilization for DNA synthesis [25] . The drastically lower dGTP accumulation in S-phase compared with G,-phase cells is expected to mitigate dG effects specifically in S-phase cells. Therefore the lack of toxic dGTP accumulation in S-phase cells accounts for the continuing DNA synthesis in S-49 cells already in S-phase, and the increasing depression of tracer incorporation into DNA over time closely parallels the gradual depletion of Sphase cells (Figs. 3 and 4) . On the other hand, the activation of RR during the G1-S transition [26] should be blocked by preexisting high dGTP levels, keeping the cells in G,-phase. Hence the double mutant, dGuo-L, with impaired feedback inhibition of RR, readily passes through the G1-S interface into S-phase, where dGTP levels rapidly drop. The continuous escape of dGuo-L cells into S-phase can therefore account for its relative resistance against dG toxicity. Furthermore, one can now propose the more general hypothesis that inhibition of RR by dGTP merely serves to keep cells in the sensitive G,-phase where other mechanisms of dGTP/dG toxicity may be operative.
The cell cycle effects of dA, i.e. a G1-S interface block, are very similar to those of dG. We have already documented that [3H]dA [in combination with erythro-9-(2-hydroxyl-3-nonyl)adenine (EHNA), an adenosine deaminase inhibitor] also accumulates slowly in the dATP of G1-but not S-phase cells of the S-49 cell lines [28] . Hence dG and dA may both exert their toxicity in the G,-phase, subsequent to a G1-S interface blockade mediated by RR inhibition. In contrast, very different effects on cell cycle progression are observed with other agents that block RR, e.g. thymidine and hydroxyurea [29, 30] which freeze cells in the Sphase. Thymidine rapidly equilibrates with the dTTP pool [27] , and hydroxyurea immediately inhibits RR, thereby preventing further DNA synthesis in S-phase cells.
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